Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/21/1995 | WO1995030748A3 Plant u14 nucleic acid sequences and derivatives thereof |
12/21/1995 | WO1995027790A3 Dna sequences coding for a cynnamoyl coa reductase and their use in the regulation of plant lignin concentrations |
12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
12/21/1995 | DE4435789C1 New peptide derived from UL57 reading frame of human cytomegalovirus |
12/21/1995 | DE4422044A1 Simple isolation and purificn. of nucleic acid from various samples |
12/21/1995 | DE4422040A1 Isolation and purificn. of PCR prods. |
12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
12/21/1995 | CA2225499A1 Epil/placentine |
12/21/1995 | CA2195083A1 Novel cell systems having specific interaction of peptide binding pairs |
12/21/1995 | CA2193072A1 Corticotropin-releasing factor2 receptors |
12/21/1995 | CA2193060A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
12/21/1995 | CA2192982A1 Ungulate eg cell |
12/21/1995 | CA2192844A1 Fas associated proteins |
12/21/1995 | CA2192823A1 Method of detecting cellular material |
12/21/1995 | CA2192689A1 Method to identify tumor suppressor genes |
12/21/1995 | CA2192662A1 Method of detecting compounds utilizing genetically modified lambdoid bacteriophage |
12/21/1995 | CA2192660A1 Methods for reducing hyperacute rejection of xenografts |
12/21/1995 | CA2192552A1 Transformation of guar |
12/21/1995 | CA2192486A1 Pp60pik: a downstream element in insulin signaling |
12/21/1995 | CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | CA2192175A1 Surface protein of staphylococcus aureus |
12/21/1995 | CA2192066A1 The production of hemoglobin having a .delta.-like globin |
12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
12/21/1995 | CA2191733A1 Methods for inhibiting antigen specific t cell responses |
12/21/1995 | CA2191441A1 Use of anthocyanin genes to maintain male sterile plants |
12/21/1995 | CA2191065A1 Compositions and methods for the treatment of tumors |
12/21/1995 | CA2169358A1 A method for displaying proteins |
12/20/1995 | EP0687737A1 Detection of herpes simplex virus, treponema pallidum and haemophilus ducreyi |
12/20/1995 | EP0687734A1 Expression system for aspergillus foetidus |
12/20/1995 | EP0687733A1 Detergent composition containing wool compatible high alkaline proteases |
12/20/1995 | EP0687732A1 Hyperthermostable beta-galactosidase gene |
12/20/1995 | EP0687731A1 Secretion vector, transformed microorganisms containing said vector and manufacture of products from said microorganism |
12/20/1995 | EP0687730A1 Method of transforming plant and vector therefor |
12/20/1995 | EP0687471A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture |
12/20/1995 | EP0687308A1 Recombinant epstein-barr viral capsid antigen useful in diagnostic method |
12/20/1995 | EP0687307A1 Inhibition of tax-mediated increase in dna binding |
12/20/1995 | EP0687306A1 $i(BORRELIA BURGDORFERI) SPIROCHAETE-SPECIFIC NUCLEIC ACID PROBES |
12/20/1995 | EP0687305A1 Esterase and its use in biotransformation |
12/20/1995 | EP0687304A1 Dna construct and method of detecting protein kinase c inhibitors using the dna construct |
12/20/1995 | EP0687303A1 Improved feedcrops enriched in sulfur amino acids and methods for improvement |
12/20/1995 | EP0687302A1 Bi-functional expression system |
12/20/1995 | EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis |
12/20/1995 | EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
12/20/1995 | EP0687299A1 Bacteriophage lc3-based vector system for transformation of bacteria |
12/20/1995 | EP0687298A1 An enzyme with rhamnogalacturonase activity |
12/20/1995 | EP0687297A1 An enzyme with arabinanase activity |
12/20/1995 | EP0687296A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
12/20/1995 | EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
12/20/1995 | EP0687272A1 Method and compositions for recombinant osteogenic protein production |
12/20/1995 | EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
12/20/1995 | EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
12/20/1995 | EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
12/20/1995 | EP0673382A4 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS. |
12/20/1995 | EP0672186A4 Improved strand displacement assay and complex useful therefor. |
12/20/1995 | EP0669933A4 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3. |
12/20/1995 | EP0633719A4 INDUCTION OF SOMATIC EMBRYOGENESIS IN -i(TAXUS), AND THE PRODUCTION OF TAXANE-RING CONTAINING ALKALOIDS THEREFROM. |
12/20/1995 | EP0541722B1 Compounds and methods for inhibiting gene expression |
12/20/1995 | EP0502036B1 Latency associated peptide and uses therefor |
12/20/1995 | EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
12/20/1995 | CN1113518A A novel peptide related to human programmed cell death and DNA encoding it |
12/19/1995 | US5477002 Isolated nucleotide sequences code for polypeptides which suppress pollen formation, genetic enginering, for hybrid seed production |
12/19/1995 | US5477001 Recombinant DNA coding for a novel protein having β-1,3-glucanase activity, bacteria containing this DNA, transformed plant cells and plants |
12/19/1995 | US5476997 Extended human hematopoiesis in a heterologous host |
12/19/1995 | US5476995 Peptide production |
12/19/1995 | US5476962 New lipopolyamines, their preparation and their use |
12/19/1995 | US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound |
12/19/1995 | US5476929 Structural gene of pneumococcal protein |
12/19/1995 | US5476926 Adipocyte-specific DNA sequences and use thereof in the production of transgenic animals exhibiting altered fat tissue metabolism |
12/19/1995 | US5476786 Host cell harboring and capable of expressing DNA encoding single chain recombinant polypeptide having site for binding preselected antigen |
12/19/1995 | US5476782 DNA encoding a human 5-HT1E receptor and uses thereof |
12/19/1995 | US5476781 Genetic engineering |
12/19/1995 | US5476779 DNA encoding insulin-like growth factor II isolated from rainbow trout |
12/19/1995 | US5476777 Methods for producing thrombin |
12/19/1995 | US5476774 Plasmid for use as internal standard |
12/19/1995 | US5476769 Hybridization technique |
12/19/1995 | US5476768 Mycobacteriophage DSGA specific for the mycobacterium tuberculosis complex |
12/19/1995 | US5476766 Ligands of thrombin |
12/19/1995 | US5476658 Vaccine against hepatitis a comprising simian HAV isolate AGM-27 |
12/19/1995 | CA2069869C Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
12/19/1995 | CA2056988C Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
12/19/1995 | CA2011654C Recombinant poxvirus host range selection system |
12/19/1995 | CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas |
12/19/1995 | CA1337753C Accelerated nucleic acid reassociation method |
12/18/1995 | CA2152036A1 Expression system, integration vector and cell transformed by said integration vector |
12/18/1995 | CA2151627A1 Recombinant gibberellin dna and uses thereof |
12/18/1995 | CA2149197A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture |
12/15/1995 | CA2150994A1 P53as protein and antibody therefor |
12/14/1995 | WO1995033997A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
12/14/1995 | WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | WO1995033854A1 Use of a specific marker for detection of salmonella with pcr |
12/14/1995 | WO1995033853A1 Fingerprinting of nucleic acids, products and methods |
12/14/1995 | WO1995033852A1 Method and probes for detecting markers bound to the locus of child spinal muscular atrophies |
12/14/1995 | WO1995033851A2 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
12/14/1995 | WO1995033846A1 Bioarray chip reaction apparatus and its manufacture |
12/14/1995 | WO1995033844A1 Method for producing heterologous bispecific antibodies |
12/14/1995 | WO1995033843A1 Deblocking the common pathway of aromatic amino acid synthesis |
12/14/1995 | WO1995033842A1 Safe retroviral vectors, their production and use |
12/14/1995 | WO1995033841A1 Locus control subregions for integration-site independent transgene expression |